List of Excipients in API bimatoprost
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bimatoprost
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | LUMIGAN | bimatoprost | 0023-3205 | BENZALKONIUM CHLORIDE | |
| Allergan Inc | LUMIGAN | bimatoprost | 0023-3205 | CITRIC ACID MONOHYDRATE | |
| Allergan Inc | LUMIGAN | bimatoprost | 0023-3205 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bimatoprost
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Sandoz Inc | bimatoprost | 0781-6206 | BENZALKONIUM CHLORIDE |
| Sandoz Inc | bimatoprost | 0781-6206 | CITRIC ACID MONOHYDRATE |
| Sandoz Inc | bimatoprost | 0781-6206 | HYDROCHLORIC ACID |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for bimatoprost
Excipient focus: BENZALKONIUM CHLORIDE
bimatoprost drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
bimatoprost drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
Excipient focus: DL-LACTIDE AND GLYCOLIDE
bimatoprost drug variants containing DL-LACTIDE AND GLYCOLIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing DL-LACTIDE AND GLYCOLIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
bimatoprost drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | bimatoprost | 0781-6206 |
| Micro Labs Limited | bimatoprost | 42571-128 |
| Alembic Pharmaceuticals Limited | bimatoprost | 46708-507 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
bimatoprost drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYLACTIDE
bimatoprost drug variants containing POLYLACTIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing POLYLACTIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
bimatoprost drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| NuCare PharmaceuticalsInc | bimatoprost | 68071-3590 |
| Fosun Pharma USA Inc | bimatoprost | 72266-139 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
bimatoprost drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | bimatoprost | 0781-6206 |
| Micro Labs Limited | bimatoprost | 42571-128 |
| Alembic Pharmaceuticals Limited | bimatoprost | 46708-507 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
bimatoprost drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| Micro Labs Limited | bimatoprost | 42571-128 |
| Alembic Pharmaceuticals Limited | bimatoprost | 46708-507 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
bimatoprost drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | bimatoprost | 60505-0583 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
bimatoprost drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | bimatoprost | 42571-128 |
| Alembic Pharmaceuticals Limited | bimatoprost | 46708-507 |
| Alembic Pharmaceuticals Limited | bimatoprost | 46708-511 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Allergan Inc | bimatoprost | 0023-9652 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
bimatoprost drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-3205 |
| Allergan Inc | bimatoprost | 0023-3616 |
| Sandoz Inc | bimatoprost | 0781-6206 |
| >Company | >Ingredient | >NDC |
bimatoprost drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | bimatoprost | 0023-9652 |
| Alembic Pharmaceuticals Limited | bimatoprost | 46708-507 |
| Alembic Pharmaceuticals Inc | bimatoprost | 62332-507 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
